Xanthogranuloma of the intrasellar region presenting in pituitary dysfunction: a case report by Nishiuchi, Takamasa et al.
CASE REPORT Open Access
Xanthogranuloma of the intrasellar region
presenting in pituitary dysfunction: a case report
Takamasa Nishiuchi
1, Koji Murao
1*, Hitomi Imachi
1, Yoshio Kushida
2, Reiji Haba
2, Nobuyuki Kawai
3, Takashi Tamiya
3
and Toshihiko Ishida
1
Abstract
Introduction: Differentiation of cystic mass lesions of the sellar and parasellar regions may pose a diagnostic
dilemma for physicians, neurosurgeons, radiologists and pathologists involved in treating patients with these
entities. A considerable number of tumors previously identified as craniopharyngiomas may, in fact, have been
xanthogranulomas. We report a case of pituitary dysfunction caused by xanthogranuloma of the intrasellar region.
Case presentation: A 47-year-old man of Japanese descent presented to our institution with a tumor located
exclusively in the intrasellar region which manifested as severe hypopituitarism. MRI revealed a clearly defined
intrasellar mass that was heterogeneously hyperintense on T1-weighted images and markedly hypointense on T2-
weighted images. We preoperatively diagnosed the patient with Rathke’s cleft cyst or non-functioning pituitary
adenoma. Although the tumor was completely removed using a transsphenoidal approach, the improvement of
the patient’s endocrine function was marginal, and continued endocrine replacement therapy was needed.
Postoperatively, a histological examination revealed the tumor to be a xanthogranuloma of the intrasellar region.
His visual field defects and headache improved.
Conclusion: Because diagnosis depends on surgical intervention and xanthogranulomas of the intrasellar region
are very rare, the natural history of xanthogranuloma is still unknown. Therefore, this entity is difficult to diagnose
preoperatively. We suggest that xanthogranuloma should be included in the differential diagnosis, even in the case
of sellar lesions, to formulate appropriate postoperative management and improve endocrine outcomes.
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Introduction
Intracranial xanthogranulomas arise most commonly in
the choroid plexus, almost uniformly in the trigone of the
lateral ventricle, whereas xanthogranulomas of the sellar
region are quite rare [1]. In some cases, a significant
degree of overlap in these features occurs, and many
xanthogranulomas of the sellar region may have been
incorrectly identified as craniopharyngiomas. One study
found that 37 craniopharyngiomas (33.6%) consisted pre-
dominantly of a xanthogranulomatous component [2].
Xanthogranulomas, also known as cholesterol granulomas,
are granulomatous lesions characterized by cholesterol
clefts, hemosiderin deposits, multi-nucleated foreign body
giant cells, foamy macrophage accumulation and fibrous
proliferation [2-6]. It is not clear, however, whether these
additional characteristics represent a distinct entity, given
the greater number of characteristics that xanthogranulo-
mas share with craniopharyngiomas. Because the diagnosis
depends on surgical intervention, the natural history of
xanthogranulomas is unknown. Therefore, it is difficult to
diagnose them preoperatively. Furthermore, when xantho-
granuloma components predominate in the lesion, differ-
ential diagnosis of various lesions with xanthogranuloma
is difficult [7,8]. Additionally, no typical radiological signs
exist for xanthogranulomas [9]. Differentiation of cystic
mass lesions of the sellar and parasellar regions may pose
a diagnostic dilemma for neurosurgeons, radiologists and
pathologists involved in treating patients with these enti-
ties. Establishing an accurate working diagnosis for sellar
region pathology or histology is critical in predicting the
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adjunctive management. Therefore, further reports are
required so that clinicians can gain greater insight into the
clinical course, management and associated outcome of
xanthogranuloma. Herein we report the case of a patient
with pituitary dysfunction caused by xanthogranuloma of
the intrasellar region.
Case presentation
A 47-year-old man of Japanese origin presented with a
history of headache, general fatigue and appetite loss of
3m o n t h s ’ duration. He was 178.2 cm in height and
weighed 57 kg. His blood pressure was 90/50 mmHg, and
his pulse was 64 beats/minute. His clinical examination
showed the patient to be alert with initial signs of upper-
visual-field defects. His physical examination revealed no
absence of axillary or pubic hair and no neurological
abnormalities. The results of the initial laboratory exami-
nations conducted to determine hormone status are pre-
sented in Table 1. The anterior pituitary provocation test
with corticotropin-releasing hormone, growth hormone-
releasing hormone, gonadotropin-releasing hormone and
thyrotropin-releasing hormone revealed impairment or
low response of the secretory functions of cortisol, adre-
nocorticotropin, growth hormone, follicle-stimulating
hormone, luteinizing hormone, thyroid-stimulating hor-
mone and prolactin (Table 2). These abnormal responses
to hormone stimulation, along with the patient’sh o r m o -
nal status, were indicative of hypopituitarism, specifically,
hypogonadotropic hypogonadism.
MRI showed a clearly defined, intra- and suprasellar
lesions with a diameter of 12 × 18 × 15 mm. The lesion
appeared as mainly isointense to gray matter with some
hyperintense areas and showed inhomogeneous contrast
enhancement in the T1-weighted images (Figures 1A
and 1B). The mass was also heterogeneously iso- or
hypointense on T2-weighted images (Figure 1C).
On the basis of the above-mentioned examinations, our
preoperative diagnosis was Rathke’s cleft cyst (RCC) or
non-functioning pituitary adenoma associated with hypo-
physitis. The lesion was completely removed by surgical
exploration via transsphenoidal selective tumorectomy 5
months after clinical onset. Our pathological examination
of the pituitary tumor revealed that the tumor was com-
posed of abundant small epithelial cells with foamy macro-
phage or lymphoid infiltration, some of which were
undergoing necrosis (Figure 2A). Hemosiderin deposits
were also observed (Figure 2B). Atypically, there was no
evidence of calcification or remarkable cholesterol clefts.
On the basis of the histopathological examination, we con-
firmed the presence of an intrasellar xanthogranuloma and
no observed cholesterol clefts.
Postoperatively, the patient’s visual field defects and
headache improved. However, he needed to continue
endocrine replacement therapy (20 mg/day of hydrocorti-
sone and 25 to 50 μg/day of thyroxine). MRI showed that
Table 1 Laboratory data of the patient
a
Parameter Laboratory data Normal range
ACTH (pg/ml) 5 4 to 48
Prolactin (ng/ml) 1.0 0 to 10
GH (ng/ml) 0.3 0 to 5
IGF-I (ng/ml) 30 264 to 542
TSH (μIU/ml) 2.013 0.3 to 5.0
ADH (pg/ml) 0.3 0.3 to 4.2
LH (mIU/ml) 0.9 > 0.5
FSH (mIU/ml) 2.7 > 1.0
Testosterone (ng/dl) < 70 330 to 740
Cortisol (μg/dl) 2.2 5 to 17.9
F-T4 (ng/dl) 0.56 0.97 to 1.69
White blood cells (cells/μl) 5700 4700 to 8700
Red blood cells (×10
4/μl) 375 400 to 540
Hemoglobin (g/dl) 11.1 13 to 17
LDH (U/l) 236 90 to 280
GOT (U/l) 65 8 to 40
GPT (U/L) 81 4 to 40
Na
+ (mEq/L) 142 135 to 145
K
+ (mEq/L) 4.4 3.5 to 5.0
Cl (mEq/L) 103 98 to 108
Ca
2+ (mg/dl) 8.4 8.5 to 10.0
Glucose (mg/dl) 74 65 to 110
Plasma osmolality (mOsm/kg H2O) 287 284 to 294
Urine osmolality (mOsm/kg H2O) 446 200 to 900
Urine 17-OHCS (mg/day) 0.6 3 to 9
Urine 17-KS (mg/day) 3.5 3 to 11
aLaboratory data are from initial evaluation. ACTH, adrenocorticotropin; GH,
growth hormone; IGF-I, insulin-like growth factor I; TSH, thyroid-stimulating
hormone; ADH,; LH, luteinizing hormone; FSH, follicle-stimulating hormone; F-
T4, free thyroxine; LDH, lactate dehydrogenase; GOT, glutamic oxaloacetic
transaminase; GPT, glutamic pyruvic transaminase; 17-OHCS, 17-
hyroxycorticosteroid; 17-KS, 17-ketosteroid.
Table 2 Results of the anterior pituitary provocation test;
adrenocorticotropic hormone and cortisol response for
corticotropin-releasing hormone stimulation, growth
hormone response for growth hormone-releasing
hormone stimulation, luteinizing hormone and follicle-
stimulating hormone response for gonadotropin-
releasing hormone stimulation
a
Parameter 0 minutes 30 minutes 60 minutes 90 minutes
TSH (μIU/ml) 2.592 5.357 5.206 4.564
PRL (ng/ml) 1 1 1 1
ACTH (pg/ml) 12 17 21 18
Cortisol (μg/dl) 4.7 6.3 8 5.4
GH (ng/ml) 0.1 1 1.2 0.9
LH (mIU/L) 0.9 3 3.4 3.2
FSH (mIU/L) 2.7 2.9 3.1 3.6
aTSH: thyroid-stimulating hormone, PRL: prolactin, ACTH: adrenocorticotropic
hormone, GH: growth hormone, LH: luteinizing hormone, FSH: follicle-
stimulating hormone.
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evidence of tumor remnants.
Discussion
The spectrum of cystic pathology occurring in the sellar
region includes craniopharyngiomas, RCCs, colloid cysts,
arachnoid cysts, cystic pituitary adenomas, epidermoid
cysts, dermoid cysts and xanthogranulomas [10,11].
Xanthogranulomas have been reported to occur at var-
ious sites inside and outside the cranial vault [2]. How-
ever, xanthogranuloma of the sellar region is very rare.
Xanthogranuloma of the sellar region was first reported
in 1988 [3], with only 4 of 211 sellar and juxtasellar
tumors (1.9%) showing the features typical of cholesterol
granulomas. Paulus et al. described and classified xantho-
granuloma of the sellar region as a distinct entity, after
which the World Health Organization accepted that
xanthogranuloma of the sellar region differs from classi-
cal craniopharyngioma in several ways: age at onset, ana-
tomical site and localization of the lesion, and symptoms
and prognosis [2,12].
The histogenesis and pathogenesis of xanthogranu-
loma remain unclear, and these details are controversial
and probably heterogeneous. It is generally thought that
Figure 1 MRI scan demonstrating a clearly defined intrasellar mass. (A) and (B) Preoperative sagittal T1-weighted MRI (T1WI) showing a
suprasellar round tumor measuring 15 × 20 mm in diameter (arrows) (A) and heterogeneous enhancement by gadolinium (Gd) contrast
medium (T1WI+Gd) (arrows) (B). (C) Coronal T2-weighted MRI (T2WI) showing the tumor as partially hypointense (arrows).
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chronic inflammatory processes in circumscribed areas
of craniopharyngiomas or at the cyst wall and adjacent
tissue of RCCs [2,13]. Degenerative changes in pituitary
adenomas also may act as triggers [3], and extreme
adeno- or infundibuloneurohypophysitis may result in
giant cell granuloma. Secondary hypophysitis can arise
from bacterial, viral and fungal infections, often in an
immunocompromised host, or from systemic disorders
such as autoimmune diseases, Langerhans histiocytosis
and Erdheim-Chester disease. On the other hand, Paulus
et al. [2] proposed xanthogranuloma of the sellar region as
a distinct entity and found hemosiderin deposits in almost
all (97%) of their 37 cases as a result of obstruction of a
cavity, hemorrhage or both. Compared to classical cranio-
pharyngiomas, xanthogranulomas characteristically occur
in adolescents and young adults, predominantly at an
intrasellar location, and are smaller in size and concomi-
tant with more severe endocrine deficiencies, but they are
more easily resected and lead to good treatment outcomes.
Craniopharyngiomas usually arise in the pituitary stalk
and grow, at least during the initial stage, mainly in the
suprasellar space. The tumor in our patient was found at a
classical location for RCCs, pituitary adenomas or hypo-
physitis, that is, the intrasellar portion and the sella turcica
[2,5,6,9], although the adenomatous lesion was not
included histologically.
Typical features of a xanthogranuloma of the sellar
region include cholesterol clefts, lymphoplasmacellular
infiltrates, marked hemosiderin deposits, multi-nucleated
foreign body giant cells around the cholesterol clefts,
accumulation of macrophages and only small epithelial
cell clusters [2]. These features have been found in
almost all cases of sellar xanthogranuloma. It is not clear,
A. 
 
 
B. 
Figure 2 Photomicrographs of the resected tumor showing that the tumor consisted of lymphoid or foamy macrophage infiltration
(A) and (B) with small clusters of epithelial cells. (A) Original magnification, ×200 (hematoxylin and eosin stain (H & E)). (B) Original
magnification, ×400 (H & E).
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a distinct entity, given the greater number of common
characteristics. Indeed, in one study, 8% of xanthogranu-
lomas of the sellar region had histological features consis-
tent with adenomatous craniopharyngioma, whereas 35%
(13 of 37) had squamous or columnar epithelium, but no
other evidence of RCCs [2]. On the basis of these consid-
erations and the histological findings in our patient, we
speculate that our patient initially may have had RCCs or
hypophysitis.
For xanthogranulomas, no typical radiological signs exist
[9]. Although it is not always possible to identify the com-
ponent of each signal intensity during surgery, researchers
speculated in a previous report that cholesterol clefts show
T1-weighted high- and T2-weighted low-signal intensities,
that hemosiderin cysts containing xanthogranuloma-like
fluid show T1-weighted high/iso- and T2-weighted high-
signal intensities and that thick fibrosis (granulation) show
both T1-weighted and T2-weighted low-signal intensities
[14]. The mixed signal intensities on both T1- and T2-
weighted images with heterogeneous enhancement reflect
their complex histologic components. The cholesterol
deposits of a xanthogranuloma appear hyperintense on
T1-weighted images; however, calcifications, micro- or
focal hemorrhages and hemosiderin deposits contained in
tumors can frequently result in heterogeneous cystic
lesions and may be essential in the formation of xantho-
granulomas as the trigger for granulomatous changes or as
a result of these changes.
A MEDLINE English-language literature search com-
mencing from 2000 revealed eight separate reports of
cases of sellar xanthogranuloma [4-7,9,15]. MRI was per-
formed in all eight of the reviewed cases (Table 3). Eight
previous cases of sellar xanthogranuloma with MRI find-
ings manifested hypo- and heterogeneous intensity on T2-
weighted imaging studies. For seven of nine reported cases
(including the present case), mixed high-intensity lesions
were seen on T1-weighted imaging and, generally, low or
heterogeneous intensity on T2-weighted imaging.
A xanthogranuloma of the sellar region usually causes
symptoms of an endocrine nature, despite favorable survi-
val outcomes for patients with xanthogranulomas. In this
case, a good outcome is defined as a socially independent
life without impairment but no recovery of endocrine func-
tion. The appropriate therapeutic strategy for most cases of
xanthogranuloma of the sellar region appears to be to cor-
rect the underlying endocrine problems first. Patients often
need to receive long-term endocrine replacement therapy
to improve their symptoms. In the eight cases of xantho-
granuloma in the literature that we reviewed, no examples
of recurring xanthogranuloma of the sellar region were
noted, and the overall outcome for patients with this con-
dition appeared to be favorable (Table 3). However, only
three of eight patients whose intrasellar tumors were
removed within 3 months of clinical onset recovered with-
out requiring endocrine replacement therapy (Table 3).
Another three patients, including the patient described in
our present case report, required medical support because
of mild hypopituitarism after the operation. The outcomes
of the other three patients were not described (Table 3).
Even if the tumor size is small, an intrasellar tumor or
delayed surgical intervention probably results in unfavor-
able endocrine outcomes. On the contrary, despite the pre-
sence of tumors 3 cm or larger in diameter, suprasellar
lesions appear to carry a better endocrinological prognosis
if appropriate treatment is initiated as soon as possible.
The increased risk of permanent pituitary dysfunction in
various sellar lesions undergoing xanthogranulomatous
reaction is probably related to their cause: hemorrhage,
inflammation or degeneration. Therefore, surgical interven-
tion early in the development of these changes may
improve pituitary function [5,6,15]. This seems to suggest
that surgical intervention within 3 months of clinical onset
and the tumor’s being in a non-intrasellar location are
important factors that result in favorable postoperative
pituitary function. It is possible that early surgical decom-
pression resulted in recovery of pituitary function in cases
3, 4 and 8, but that chronic inflammation in cases 1, 5 and
9 resulted in destruction and fibrosis of the pituitary as
well as irreversible hormonal deficits (Table 3).
Conclusion
Because xanthogranulomas of the sellar region are rare,
their nature and clinical course remain somewhat unclear.
The seriousness of the hypopituitarism, the hyperintensity
of T1-weighted MRI or hypointensity of T2-weighted
MRI, and the absence of calcification should alert clini-
cians to the possibility that the tumor may be a xanthogra-
nuloma. Therefore, xanthogranulomas should be included
in the preoperative differential diagnosis of intrasellar
tumors. Moreover, we suggest that such tumors should be
treated as soon as possible, within a minimum of 3 to 4
months, especially in the case of tumors occupying the
intrasellar region, to improve endocrinological outcomes,
even if the tumors seem small.
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